MeiraGTx Holdings plc Profile Avatar - Palmy Investing

MeiraGTx Holdings plc

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following…

Biotechnology
US, New York [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of MGTX's Analysis
CIK: 1735438 CUSIP: G59665102 ISIN: KYG596651029 LEI: - UEI: -
Secondary Listings
MGTX has no secondary listings inside our databases.